Skip to main content

Animations

MJFF Publications

1021 - 1030 of 8404 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Evaluation of an Adapted Semi-Automated DNA Extraction for Human Salivary Shotgun Metagenomics
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3390/biom13101505
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Adaptor protein-3 produces synaptic vesicles that release phasic dopamine
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2309843120
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-023-01653-3
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Magnetic Resonance Imaging Biomarkers of Punding in Parkinson’s Disease
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci13101423
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Machine learning nominates the inositol pathway and novel genes in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awad345
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Pathogenic variants in the Longitudinal Early‐onset Alzheimer's Disease Study cohort
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.13482
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson’s Disease
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms241914915
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Predicting cognitive decline in a low-dimensional representation of brain morphology
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-43063-4
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.91645
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Patients with progressive supranuclear palsy need to be seen sooner and more frequently
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105883
    Best OA location URL:
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.